Dermavir ICO: Company Review and DVT Token News Updates

Dermavir ICO (DVT Coin): Genetic Immunity's Cryptocurrency?

The company, Genetic Immunity Inc. is a new ICO that is backing the development of the HIV vaccine Dermavir. You can participate on the Initial Coin Offering soon, and if you want to follow them you can on Twitter and Telegram. They also have open whitelist registration on the company website as well.

All of the content on the website is copyrighted to Genetic Immunity Inc. an ERC20 based Token platform. There is also contact information as well on the home page. As of now, they are the only ICO I know of that is looking to support the development, testing, and distribution of Dermavir.

How Does Dermavir Genetic Immunity's Cryptocurrency Work?

The company is a privately own clinical stage biotechnology firm that is focused on the development of new vaccines and their different phases of being issued to the public. They are looking into revolutionary new ideas for different immune therapy technologies that will help to improve or treat viral infections, caners and allergies as well as other chronic illnesses.

The immune therapies on the website right now are currently focused around Dermavir, a new vaccine that is trials on monkeys and used as a vaccination for HIV. They are using disease specific antigens that are optimized for plasmid DNA. As well as Nano-Medicines formulated to encompass the plasmid DNA so that it closely resembles a virus.

The vaccine is primarily being used as a topical solution through the sin that will deliver cells directly to the lymph nodes of the immune system. The digital personal medicine companion diagnostic software used by the company is built entirely on blockchain technology. It is allowing users to find the optimal vaccine product for any specific given virus or disease.

Dermavir DVT Token ICO Details

The ICO for the company is currently in Pre-Sale with the tokens being ready and available in a little more than eight days. Until the pre-register opens, you can get in on the pre-registration on the company website as well. Pre-registering will put you on the whitelist, so you can be one of the first people to be notified of the ICO when it launches. They will also keep you up to date with all the latest breakthroughs about the vaccine and how you can best participate with the company.

The company is raising funds to complete the regulatory documentation that is needed by the US FDA. And to complete the platform for investors that is built on blockchain technology to match viruses with the best vaccine possible. They are making it one of the most accurate, effective, protected platforms anywhere online. They will give users a private chain, genetic wallet and private keys that hold public key structures.

Who Is Behind Dermavir?

The company behind the platform is Genetic Immunity Inc. a powerful company that is looking to help with the creation and distribution of the HIV vaccine. Apparently, it has shown in incredible promise in monkeys, thereby significantly dropping the AIDS rates that has occurred as well as the time for treatment. The vaccine has to go through several phases like any other medication would, especially before it is ready for human trials.

The whitepaper on the company website has a ton of information on the vaccine and the current phases it has to go through. It also discloses information on where it’s at right now and stats with the results that are being produced from the vaccine Dermavir. Apparently, there are future products that are also being developed to help with pharma online. The purpose of Genetic Immunity Inc. is to create a platform where investors can invest into pharma they believe to be beneficial to the medical society and its patients.

The team is headed by Mr. Vikto Rosnyay, the CEO and chairman of the company since November of 2013. He’s also the CEO of Power of the Dream Ventures, a venture capital team. Not only that, but he has played the biggest role in the creation of Genetic Immunity Inc. And is also responsible for the hiring of FDA consultant who is helping ensure that the company is running at maximum levels of efficiency. He’s highly specialized in the teach industry and investing and has been involved in several positive, very successful companies. Not only that, but he has verified social media profiles as well. He’s only one many of the team of many behind the platform.

There are currently three other people on the platform who are involved in making sure that Genetic Immunity Inc. runs proficiently through its ICO and various stages of development. They are all highly educated people with different backgrounds in the tech field, investing and medical industries. Each of them also has a verified LinkedIn profile as well. Many of the people listed on the platform are advisors who are also helping ensure the platform moves forward with prompt speediness and proficiency.

Dermavir Conclusion

The company is promising because of the different technologies they are currently using for rapid results. And to better develop the original versions of the vaccinations. Their lead therapy is for that of HIV treatment and is known as Dermavir. It’s effective in boosting the immune response to killing HIV-infected cells. Human clinical trials are in phase 1 and phase 2. The second phase has shown the vaccine has the capabilities to kill cells infected with the HIV virus. DirmaVir also is said to have one of the best safety profiles, as safe as placebos and it may be used in conjunction with other antiretroviral therapy.

If you’re interested in becoming a part of the platform for the purpose of investing or to seek assistance with vaccinations because of health reasons, you can learn more at Dermavir.com. This is still a new platform, but could end up becoming one of the largest in history if they are able to effectively treat those people who are infected with the HIV retro-virus.